GLP or GCP for bioanalysis? [GxP / QC / QA]

posted by ElMaestro  – Belgium?, 2019-01-20 10:42  – Posting: # 19787
Views: 1,802

Hi all,

more confusion at my end, it is something very basic.

EU guideline on BE: "The bioanalytical part of bioequivalence trials should be performed in accordance with the principles of Good Laboratory Practice (GLP)"

EU guideline on method validation: "The validation of bioanalytical methods and the analysis of study samples for clinical trials in humans should be performed following the principles of Good Clinical Practice (GCP)"

So, which guideline(s) must a CRO follow for sample analysis for EU studies: GLP or GCP or both?
Does validation "only" need to comply with GCP and if yes, can you give a practical example of the real difference?

If you are saying both GLP and GCP need to be observed in some cases then I may have a natural question about the meaning of the term "principal investigator"....:-)

I could be wrong, but...
Best regards,
ElMaestro

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,688 posts in 4,178 threads, 1,352 registered users;
online 6 (0 registered, 6 guests [including 4 identified bots]).
Forum time (Europe/Vienna): 16:43 UTC

An expert is one who knows more and more
about less and less.    Nicholas Murray Butler

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5